Leaderboard
Anzeige
Fr
|
De
Feedback
|
Impressum
|
Sitemap
Aucun choix d'articles!
Panier
Vous êtes ici:
Recherche de documentation spécialisée
»
Voies biliaires
»
Néoplasie
26. Octobre 2025
Recherche
Gastroplattform
Néoplasie
Recherche avancée
Dépistage / diagnostic
Traitements
Directives
Perfectionnement
Nouvelles
Recherche de documentation spécialisée
Voies biliaires
Cholécystite - Cholélithiase
Néoplasie
Autres
Foie
Estomac / intestins
Œsophage
Pancréas
Congrès et sessions
Services et outils
Liens
Rect Top
Anzeige
Écriture:
Page 1 de 828
Articles 1 - 20 / 16543
Percutaneous Transhepatic Biliary Intervention for The Management of Malignant Hilar Biliary Obstruction.
Korean J Gastroenterol
Vo QH, Le MT, Ngo DHA, Le BKM, Ho HT, Le TK, Nguyen TT, Dang QH, Le HH, Le TB.
PMID: 41132023 [PubMed - indexed for MEDLINE]
Selective lymph node dissection in intrahepatic cholangiocarcinoma and combined hepatocellular cholangiocarcinoma may not impair oncological outcomes: a single-center retrospective cohort study.
World J Surg Oncol
Lu WH, Liao TK, Su CM, Yang TH, Chou TC, Su PJ, Wang CJ, Chao YJ, Lin YJ, Shan YS.
PMID: 41121221 [PubMed - indexed for MEDLINE]
Anti-PD1 antibody toripalimab combined with lenvatinib, or GEMOX chemotherapy combined with lenvatinib as first-line therapy in patients with advanced intrahepatic cholangiocarcinoma: a randomized, open, two-cohort Phase 2 Study.
BMC Med
Huang XY, Shi GM, Zheng ZT, Sun HC, Liang F, Ji Y, Chen Y, Yang GH, Hu ZQ, Lu JC, Meng XL, Guo XJ, Zhang CC, Fan J, Zhou J.
PMID: 41121202 [PubMed - indexed for MEDLINE]
Survival rate of patients with combined hepatocellular cholangiocarcinoma receiving medical cannabis treatment: A retrospective, cohort comparative study.
F1000Res
Phansila N, Pansila P, Wongkongdech A, Turnbull N, Azam M, Wongkongdech R.
PMID: 41113085 [PubMed - indexed for MEDLINE]
The Landscape of Genomic Alterations in Receptor Tyrosine Kinase Pathways in Biliary Cancers: Implications for Targeted Therapies.
J Gastrointest Cancer
Voutsadakis IA.
PMID: 41109905 [PubMed - indexed for MEDLINE]
Gallbladder and cystic duct paraganglioma equiring cystic duct Re-excision.
BMJ Case Rep
Abdelaziz R, Ayoub G, Elberm H, Tarek R, Abu Hazeem J.
PMID: 41107044 [PubMed - indexed for MEDLINE]
Identifying occult high-risk features and stratified management strategies following curative resection for ampullary adenocarcinoma.
Cancer Biol Med
Ma X, Meng C, Shi X, Zhang Z, Li Q, Wang H, Liang Y, Gao S, Wang X, Gao C, Wang J, Ma W, Feng Y, Li S, Chen X, Li W, Shi S, Zhou T, Yu J, Hao J.
PMID: 41105474 [PubMed - indexed for MEDLINE]
Construction and validation of a novel prognostic model for postoperative patients with stage I intrahepatic cholangiocarcinoma: a population-based study.
Langenbecks Arch Surg
Yao X, Fan X, Wang Q, Zhou H, Wang H, Hu H.
PMID: 41102539 [PubMed - indexed for MEDLINE]
Cholangiocarcinoma - Morphology, Immunohistochemistry, and Genetics.
Cesk Patol
Hrudka J, Mat.
PMID: 41102000 [PubMed - indexed for MEDLINE]
Pitfalls of extrahepatic bile duct cytology.
Cesk Patol
Kurfürstová D, Slobodová Z.
PMID: 41101999 [PubMed - indexed for MEDLINE]
Multi-Phase Contrast-Enhanced CT Clinical-Radiomics Model for Predicting Prognosis of Extrahepatic Cholangiocarcinoma After Surgery: A Single-Center Retrospective Study.
Chin Med Sci J
Zhang SB, Wang Z, Hu G, Cheng SH, Wang ZW, Jin ZY.
PMID: 41099185 [PubMed - indexed for MEDLINE]
Single-cell multi-omics in biliary tract cancers: decoding heterogeneity, microenvironment, and treatment strategies.
Mol Biomed
Tang N, Li J, Gu A, Li M, Liu Y.
PMID: 41091402 [PubMed - indexed for MEDLINE]
Long-Term Outcomes of Combined Hepatocellular Carcinoma-Cholangiocarcinoma After Liver Transplantation in Patients with or without Concurrent Hepatocellular Carcinoma.
Ann Transplant
Jeong IJ, Hwang S, Ahn CS, Moon DB, Ha TY, Song GW, Jung DH, Park GC, Kang WH, Yoon YI, Lee SG.
PMID: 41084225 [PubMed - indexed for MEDLINE]
Long-term survival after targeted therapy plus immunotherapy without chemotherapy in advanced gallbladder carcinoma: a case report and literature review.
Front Immunol
Chen Z, Wu Y, Ding C, Gu Y, Wu W, Li Q.
PMID: 41080570 [PubMed - indexed for MEDLINE]
Do Incretin-Based Therapies Influence the Risk of Cholangiocarcinoma in Type 2 Diabetes Patients? Insights from a Systematic Review and Meta-Analysis.
J Gastrointest Cancer
Yonatan ER, Jusni LFJ, Alvianto S, Widjanarko ND, Usman SY, Muzellina VN.
PMID: 41075111 [PubMed - indexed for MEDLINE]
Endoscopic Ultrasound-Guided Biliary Drainage (EUS-BD) for malignant biliary obstruction after failed endoscopic retrograde cholangiography (ERC) in patients with surgically altered anatomy.
Z Gastroenterol
Thuemer S, Meyer F, Fueldner F, Will U.
PMID: 41061738 [PubMed - indexed for MEDLINE]
Quantitative nodal burden as a predictive marker for chemotherapy benefit in postoperative ampullary adenocarcinoma: a multi-institution population-based study.
Front Immunol
Li Z, Sun C, Li Z, Fei H, Xing C, Zhao D.
PMID: 41050678 [PubMed - indexed for MEDLINE]
Review: Progress of the NLRP3 inflammasome in tumours and perspectives for cholangiocarcinoma.
Cell Commun Signal
Zhuo Z, Xie Y, Zou H, Tan B, Dong Q, Dong B, Zhu C.
PMID: 41035012 [PubMed - indexed for MEDLINE]
Gemcitabine and Cisplatin Plus Polymeric Micellar Paclitaxel and Survival in Advanced Biliary Tract Cancer: A Randomized Clinical Trial.
JAMA Netw Open
Jeong H, Yoo C, Kim I, Kang JH, Jeong JH, Park K, Oh SB, Park I, Sym SJ, Cheon J, Ryu H, Hwang JE, Lee JS, Ryoo BY, Kim KP.
PMID: 41032300 [PubMed - indexed for MEDLINE]
The clinical value of lymph-node dissection in hepatitis B virus-associated intrahepatic cholangiocarcinoma.
Medicine (Baltimore)
Zhong FP, Tan XQ, Wang XF, Peng H, Qiu Y.
PMID: 41029072 [PubMed - indexed for MEDLINE]
Articles 1 - 20 / 16543
Page 1 de 828
Rect Bottom
Anzeige
Adserver Footer
Intervalle de temps demandé
--sans limitation--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy
|
Publicité